Copyright ©The Author(s) 2020.
World J Stem Cells. Jun 26, 2020; 12(6): 471-480
Published online Jun 26, 2020. doi: 10.4252/wjsc.v12.i6.471
Table 1 Characteristics of published clinical trials
ID                  ConditionCell typeCasePhaseDurationResult
NCT00683722COPDProgenitor cells62II2 yrNo infusional toxicities, deaths, and SAE
NCT01110252COPD/ EmphysemaBM-MSCs4NA1 yrNo SAE; significant improvement in the quality of life and clinical conditions
NCT01306513EmphysemaBM-MSCs10I8 wkNo SAE; increased CD31 expression
NCT01775774ARDSBM-MSCs9I8 wkNo infusional toxicities, no SAE
NCT02097641ARDSBM-MSCs60II8 wkNo SAE; improve MV and PEEP
NCT00257413PAHEPCs31NA12 wkNo SAE; increased MWD, PAP, PVR, and cardiac output
NCT00469027PAHEPCs7I1 yrWell tolerated; increased MWD
NCT02181712BOSMSC9I4 wkNo SAE